Publications


2025

Incidence and Risk Factors of Interval and Screen-Detected Breast Cancer.

Zhang Y, Rodriguez J, Mao X, Grassmann F, Tapia J, Eriksson M, Hall P, Czene K.


JAMA Oncol
202503
https://pubmed.ncbi.nlm.nih.gov/40146116/

Interactions Between Genetic and Epidemiological Factors Influencing Mammographic Density.

Suger AH, Chen H, Haas CB, Fan S, Scott CG, Bolla MK, Dennis J, Dunning AM, Michailidou K, Wang Q, Fasching PA, Haeberle L, Stone J, Gago-Dominguez M, Castelao JE, Murphy RA, Aronson K, Couch FJ, Yadav S, Milne RL, Hopper JL, Norman A, Eliassen AH, Tapper WJ, Eccles DM, Evans DG, Astley S, Hall P, Czene K, et al.


Am J Epidemiol
202503
https://pubmed.ncbi.nlm.nih.gov/40153356/

Evaluation of a digital reporting and supporting tool in breast cancer prevention trials (KarmApp).

Tapia J, Gabrielson M, Hammarström M, Wengström Y, Bergqvist J, Tuuliainen A, Eriksson M, Czene K, Hall P, Bäcklund M.


BMC Health Serv Res.
202503
https://pubmed.ncbi.nlm.nih.gov/40045306/

2024

Swedish Genome-Wide Haplotype Association Analysis Suggests Breast Cancer Loci with Varying Risk-Modifying Effects.

Vermani L, Barnekow E, Liu W, Wendt C, Hall P, Margolin S, Lindblom A.


Genes
202412
https://pubmed.ncbi.nlm.nih.gov/39766883/

Low-dose tamoxifen treatment reduces collagen organisation indicative of tissue stiffness in the normal breast: results from the KARISMA randomised controlled trial.

Göransson S, Hernández-Varas P, Hammarström M, Hellgren R, Bäcklund M, Lång K, Rosendahl AH, Eriksson M, Borgquist S, Strömblad S, Czene K, Hall P, Gabrielson M.


Breast Cancer Res.
202411
https://pubmed.ncbi.nlm.nih.gov/39593191/

Influence of endoxifen on mammographic density-results from the KARISMA trial.

Hammarström M, Gabrielson M, Bergqvist J, Lundholm C, Crippa A, Bäcklund M, Wengström Y, Borgquist S, Eliasson E, Eriksson M, Tapia J, Czene K, Hall P.


J Natl Cancer Inst.
202411
https://pubmed.ncbi.nlm.nih.gov/39514025/

WHO-recommended levels of physical activity in relation to mammographic breast density, mammographic tumor appearance, and mode of detection of breast cancer.

Boraka Ö, Sartor H, Sturesdotter L, Hall P, Borgquist S, Zackrisson S, Rosendahl AH.


Breast Cancer Res.
202409
https://pubmed.ncbi.nlm.nih.gov/39304951/

Studying the association Between longitudinal non-dense breast tissue and breast cancer risk: a joint modelling approach

Illipse M, Gasparini A, Christoffersen B, Hall P, Czene K, Humphreys K.


Am J Epidemiol
202407
https://pubmed.ncbi.nlm.nih.gov/39004517/

Association of area- and volumetric-mammographic density and breast cancer risk in women of Asian descent: a case control study

Mariapun S, Ho WK, Eriksson M, Mohd Taib NA, Yip CH, Rahmat K, Hall P, Teo SH.


Breast Cancer Res.
202405
https://pubmed.ncbi.nlm.nih.gov/38750574/

Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization.

Haas CB, Chen H, Harrison T, Fan S, Gago-Dominguez M, Castelao JE, Bolla MK, Wang Q, Dennis J, Michailidou K, Dunning AM, Easton DF, Antoniou AC, Hall P, Czene K, et al.


Breast Cancer Res.
202404
https://pubmed.ncbi.nlm.nih.gov/38653906/

Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change

Gabrielson M, Hammarström M, Bergqvist J, Lång K, Rosendahl AH, Borgquist S, Hellgren R, Czene K, Hall P.


Int J Cancer
202403
https://pubmed.ncbi.nlm.nih.gov/38554131/

Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer.

Xiao Q, Mao X, Ploner A, Grassmann F, Rodriguez J, Eriksson M, Hall P, Czene K.


J Natl Cancer Inst.
202402
https://pubmed.ncbi.nlm.nih.gov/38366028/

Investigation of Genetic Alterations Associated With Interval Breast Cancer.

Rodriguez J, Grassmann F, Xiao Q, Eriksson M, Mao X, Bajalica-Lagercrantz S, Hall P, Czene K.


JAMA Oncol.
202401
https://pubmed.ncbi.nlm.nih.gov/38270937/

Breast Cancer Incidence After a False-Positive Mammography Result.

Mao X, He W, Humphreys K, Eriksson M, Holowko N, Yang H, Tapia J, Hall P, Czene K.


JAMA Oncol
202401
https://pubmed.ncbi.nlm.nih.gov/37917078/

2023

The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk.

Grassmann F, Mälarstig A, Dahl L, Bendes A, Dale M, Thomas CE, Gabrielsson M, Hedman ÅK, Eriksson M, Margolin S, Huang TH, Ulfstedt M, Forsberg S, Eriksson P, Johansson M, Hall P, Schwenk JM, Czene K.


Epub
202312
https://pubmed.ncbi.nlm.nih.gov/38135714/

Comparing the diagnostic accuracy, reading time, and inter-rater agreement of breast MRI abbreviated and full protocols: a multi-reader study

Hellgren R, Tolocka E, Saracco A, Wilczek B, Sundbom A, Hall P, Dickman PW.


Epub
202312
https://pubmed.ncbi.nlm.nih.gov/38115682/

Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation.

Mälarstig A, Grassmann F, Dahl L, Dimitriou M, McLeod D, Gabrielson M, Smith-Byrne K, et al.


Nat Commun
202311
https://pubmed.ncbi.nlm.nih.gov/37996402/

Breast Cancer Incidence After a False-Positive Mammography Result.

Mao X, He W, Humphreys K, Eriksson M, Holowko N, Yang H, Tapia J, Hall P, Czene K.


JAMA Oncol
202311
https://pubmed.ncbi.nlm.nih.gov/37917078/

Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer.

Wichert K, Hoppe R, Ickstadt K, Behrens T, Winter S, Herold R, Terschüren C, et al.


Eur J Epidemiol
202310
https://pubmed.ncbi.nlm.nih.gov/37789226/

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. 

Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, et al.


J Med Genet
202309
https://pubmed.ncbi.nlm.nih.gov/27595995/